[Upcoming Webinar] Successful Approaches from Rare Disease and Cellular & Gene Therapy Product Approvals
Register now for the Rare Disease Day webinar to join the discussion with Medpace experts on successful approaches to achieve cellular and gene therapy approvals…
Medpace Partners with FindMeCure’s TrialHub to Strengthen Patient Education through EUPATI Scholarships
Medpace is pleased to announce that, through its work with FindMeCure’s TrialHub, a donation has been made to the EUPATI scholarship programme for patient education…
[On-Demand Webinar] Considerations for Patient Diversity in Cardiovascular Clinical Trials
Join our featured speakers as they discuss challenges and considerations surrounding the recruitment and retention of diverse patient populations to ensure appropriate representation in clinical research.
4 Key Considerations for Designing Immuno-Oncology Trials
As more agents approach the clinic, it is imperative for researchers to consider the design and conduct of immuno-oncology clinical trials. Given the diversity of…
Medpace Strengthens Relationships with Key European Sites
To build a strong network of reliable, key sites Medpace established the Flagship site program consisting of the best-performing sites dedicated to best practices, expedited…
Patient-Focused Clinical Trial Design for Rare Diseases – Part 2
In our previous post, we discussed how patient-focused clinical trial design and collaborative approaches to site enrollment can accelerate rare disease clinical research. Yet, as…
Patient-Focused Clinical Trial Design for Rare Diseases – Part 1
A few months ago, Medpace and the Cincinnati Children’s Hospital Medical Center presented a webinar on the importance of patient-centric clinical research. Over the next…
How to Identify, Enroll, and Retain Rare Disease Populations in Clinical Trials
Enrolling enough subjects into a rare disease study can seem like an insurmountable challenge, especially when you're looking at a subset of a rare disease,…